Recurrent mutations of DDX3X are also found in Natural killer (NK)/T-cell lymphoma (NKTCL), with a positive correlation between DDX3X mutations and poor clinical outcome (Jiang et al., 2015). This evidence concerns the gene DDX3X and T-cell non-Hodgkin lymphoma.